ArticleThe Journal of pharmacology and experimental therapeutics2016

β Adrenergic Receptor Kinase C-Terminal Peptide Gene-Therapy Improves β2-Adrenergic Receptor-Dependent Neoangiogenesis after Hindlimb Ischemia.

Alessandro Cannavo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.